'Small cell lung cancer' presentation slideshows

Small cell lung cancer - PowerPoint PPT Presentation


Lung Cancer

Lung Cancer

Lung Cancer What Is Lung Cancer? Lung cancer is the leading cause of cancer death for men and women. It is also the most preventable form of cancer. Tobacco use accounts for 87% of lung cancers. There are two major types of lung cancer: 1. Non-small cell lung cancer (87%)

By jacob
(459 views)

Small Cell Lung Cancer

Small Cell Lung Cancer

Small Cell Lung Cancer. Sam Wang. Outline. Small Cell Lung Cancer. SCLC - Background. SCLC Incidence: ACS 2007: All Lung CA incidence: 213,000 13% of all lung CA (~27,000). Natural History of SCLC.

By Roberta
(460 views)

NON-TRADITIONAL ENDPOINTS IN LUNG CANCER - Patient Reported Outcomes -

NON-TRADITIONAL ENDPOINTS IN LUNG CANCER - Patient Reported Outcomes -

NON-TRADITIONAL ENDPOINTS IN LUNG CANCER - Patient Reported Outcomes -. Richard J. Gralla, MD New York Lung Cancer Alliance New York, New York. TRIALS. MANAGEMENT. SURVIVAL. Appropriate if Survival Difference is likely. Not relevant for individual patients. RESPONSE.

By Patman
(358 views)

New treatment options for lung cancer

New treatment options for lung cancer

New treatment options for lung cancer. Lung cancer is a leading cause of death world wide 90% of lung cancer is caused by smoking 20% of patients are suitable for surgery 5% of all cases have 5 year survival. Most of the patients are in advanced stages and have very poor prognosis

By Anita
(600 views)

Pulmonary Neoplasia

Pulmonary Neoplasia

Pulmonary Neoplasia. Lung Neoplasms. Primary benign (rare) malignant (very common) Metastatic (Very common). Male 21 – metastatic osteosarcoma. Suspicious lesion on CXR…. Lung abscess (surgical resection). Primary Lung Cancer. The Size of the Problem 1.

By jaden
(375 views)

Meeting Agenda

Meeting Agenda

Meeting Agenda. Presentations on endpoints Regulatory issues Scientific issues Pros and cons of end points Classical end points Non-classical end points End points and trial designs according to lung cancer stage. Presentations . Regulatory background General regulatory requirements

By daniel_millan
(258 views)

RTKs and rational cancer therapy

RTKs and rational cancer therapy

RTKs and rational cancer therapy. Dr Andrejs Liepins/Science Photo Library. Are we making progress?. In looking at “5-year” survival, we need to remember we are are making a LOT of progress in cancer detection for some cancers.

By omer
(226 views)

Plants Used In Cancer Treatment

Plants Used In Cancer Treatment

Plants Used In Cancer Treatment. Part - II. Mayapple - Podophyllum peltatum. Perennial plant in the barberry family (Berberidaceae) Description Distribution Well known poisonous plant. Traditional uses of mayapple. Rhizomes dried and ground to a powder Powerful purgative

By paul2
(507 views)

Pancoast’s Tumor

Pancoast’s Tumor

Pancoast’s Tumor. Sallie Ruth Coleman December 15, 2008. Outline. What is it? What else could it be? Clinical Presentation Imaging Work-Up Treatment Prognosis What next?. Henry Pancoast: early 20 th century One region…Many names Location. Introduction. Malignant Tumor

By kovit
(766 views)

Respiratory Stressors I

Respiratory Stressors I

Respiratory Stressors I. Pulmonary Embolism Lung Cancer Thoracic Surgery Chest Tubes Pleural Effusions. Pulmonary Embolism. Pulmonary Embolism -emboli that reach the lungs and obstruct pulmonary circulation -blood, air, fat, tumor cells, amniotic fluid, foreign objects

By aquarius
(313 views)

Thoracic Surgery Innovations And Complications

Thoracic Surgery Innovations And Complications

Thoracic Surgery Innovations And Complications . Overview. Innovations Complications. Innovations. VATS LVRS Chemotherapy Radiotherapy PET Small Cell N2 Stents & Lasers Stapler In Oesophagogastrectomy Epidural SVC stents. Complications. ?. Complications. Air Leak Atalectasis

By shelly
(321 views)

RTKs and rational cancer therapy

RTKs and rational cancer therapy

RTKs and rational cancer therapy. Dr Andrejs Liepins/Science Photo Library. Are we making progress?. In looking at “5-year” survival, we need to remember we are are making a LOT of progress in cancer detection for some cancers.

By elle
(220 views)

Nausea and Vomiting

Nausea and Vomiting

Nausea and Vomiting. Mark Feldman, MD. Case Report.

By arich
(961 views)

Thoracic Surgery

Thoracic Surgery

Thoracic Surgery. Overview. What is it ? What do you need to know as a nurse on the ward ?. What do you need to know as a nurse on the ward ?. Different pathologies Different operations Chest drains Post operative care. Different pathologies. Lung cancer Pneumothorax Pleural effusions

By kasa
(330 views)

How to compute CI’s – standard approach vs floating absolute risk

How to compute CI’s – standard approach vs floating absolute risk

How to compute CI’s – standard approach vs floating absolute risk. GCRC Breakfast Workshop Series January 16, 2004 Patrick G. Arbogast Dept. of Biostatistics. Motivation. Recently, collaborators from Million Women Study published investigation of HRT & breast cancer risk ( Lancet , 2003).

By lancelot
(186 views)

New treatment options for lung cancer

New treatment options for lung cancer

New treatment options for lung cancer. Lung cancer is a leading cause of death world wide 90% of lung cancer is caused by smoking 20% of patients are suitable for surgery 5% of all cases have 5 year survival. Most of the patients are in advanced stages and have very poor prognosis

By dallon
(180 views)

Stage I Lung Radiosurgery: Overview, Results, and Current RTOG Studies

Stage I Lung Radiosurgery: Overview, Results, and Current RTOG Studies

Stage I Lung Radiosurgery: Overview, Results, and Current RTOG Studies. Douglas Johnson, MD, FACR Florida Radiation Oncology Group ACRIN Sept 2010 Annual Meeting. Stereotactic Body Radiotherapy. High ablative dose SRS= single Fx SBRT= 2-5 Fx

By jana
(473 views)

Lung Cancer

Lung Cancer

Lung Cancer. What Is Lung Cancer?. Lung cancer is the leading cause of cancer death for men and women. It is also the most preventable form of cancer. Tobacco use accounts for 87% of lung cancers. There are two major types of lung cancer: 1. Non-small cell lung cancer (87%)

By kimn
(184 views)

Horizon scanning for managing medicines

Horizon scanning for managing medicines

Horizon scanning for managing medicines. Produced by UKMi to support the Prescribing Outlook series November 2007. Horizon scanning . What is horizon scanning? Why is it necessary? How is it done? What will be the key pressures on medicines budgets in the NHS in 2007-2008?.

By ozzie
(224 views)

IRESSA ® (ZD1839) Monotherapy for Non-Small Cell Lung Cancer (NSCLC)

IRESSA ® (ZD1839) Monotherapy for Non-Small Cell Lung Cancer (NSCLC)

ONCOLOGY. IRESSA ® (ZD1839) Monotherapy for Non-Small Cell Lung Cancer (NSCLC). Oncologic Drugs Advisory Committee Meeting September 24, 2002. IRESSA ® Introduction. George Blackledge, MD Clinical Vice President, Oncology AstraZeneca Pharmaceuticals. IRESSA ® Agenda for Today’s Meeting.

By penn
(148 views)

View Small cell lung cancer PowerPoint (PPT) presentations online in SlideServe. SlideServe has a very huge collection of Small cell lung cancer PowerPoint presentations. You can view or download Small cell lung cancer presentations for your school assignment or business presentation. Browse for the presentations on every topic that you want.